CLOs on the Move

Dental USA Inc

www.mydentalusa.com

 
Dental USA Inc is a Mchenry, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

StarPoint Co

StarPoint Co is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Canon City, CO. To find more information about StarPoint Co, please visit www.starpointco.com

Aptihealth

Aptihealth is improving higher acuity behavioral healthcare for underserved populations—one member at a time. The company`s virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Boston and employing over 150, aptihealth has raised over $65 million in funding from leading international equity firms. The company`s care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction.

Myocor

Myocor is a Osseo, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Contessa Healthcare

Contessa operates a risk based model, Home Recovery Care, that combines all the essential elements of inpatient hospital care in the comfort of patients` homes. We bring together our evidenced-based home recovery care models for acute care, post-acute care and surgical procedures with administrative support services and a proprietary health informatics platform.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.